Navigation Links
Democratic Candidates Miss Key Health Issue in Debate
Date:2/26/2008

Candidates Are Ignoring the Fight Against Cancer

CLEVELAND, Feb. 26 /PRNewswire-USNewswire/ -- Senators Hillary Clinton and Barack Obama took the stage for a final debate before the March 4 primaries. The candidates addressed many troubling matters important to the American public but fell short on a critical health issue -- breast cancer. Breast cancer is an issue identified by 62 percent of Americans as the key health issue facing women today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

"Senators Hillary Clinton and Barack Obama gave us a wide-ranging and informative discussion of issues important to all Americans," said Diane Balma, head of Susan G. Komen for the Cure Advocacy Alliance. "But we are disappointed that breast cancer, which takes the lives of almost 2,000 women in Ohio each year, was not even mentioned during the debate. In fact, Ohio ranks fourth in the nation for breast cancer mortality."

A recent nationwide survey commissioned by the Komen Advocacy Alliance revealed voters' attitudes about health care, breast cancer and the 2008 election. More than 90 percent of voters want the federal government to pay more attention to breast cancer research, screening and early detection and access to quality care for all. A majority of voters (62 percent) believe breast cancer is the most critical health problem facing women today. But only one in 10 voters is aware of their preferred presidential candidate's position on issues relating to breast cancer.

"Breast cancer, and cancer in general, is indicative of the barriers, gaps and disparities inherent in the U.S. health care system," added Balma. "Women without insurance, racial and ethnic minorities, and women in underserved areas are less likely to receive the care they need and are more likely to die from the disease. The candidates are missing a ripe opportunity to draw distinctions between their health care policies and inform voters on how they plan to end breast cancer and its disparities."

The Komen Advocacy Alliance has launched a special project, I Vote for the Cure(TM), to educate voters and challenge the presidential candidates to make breast cancer a national priority. I Vote for the Cure(TM) is challenging candidates to address three achievable goals that will save lives and help end breast cancer forever: increasing investment in translational research, improving access to screening, and ensuring quality treatment for all women. For more information, visit http://www.IVotefortheCure.org.

About the Susan G. Komen for the Cure Advocacy Alliance

Nancy G. Brinker promised her dying sister, Susan G. Komen, that she would do everything in her power to end breast cancer forever. In 1982 that promise became Susan G. Komen for the Cure, and since then the organization has been at the forefront of a global fight against breast cancer. Through the newly formed Susan G. Komen for the Cure Advocacy Alliance, a tax-exempt, 501c4 nonpartisan organization, Komen for the Cure is taking the next logical next step in its evolution: expanding its reach in the health policies arena. With the freedom to actively lobby for life-saving breast cancer public policy change, the Komen Advocacy Alliance will directly engage policymakers and opinion leaders to advocate for increased funding for breast cancer research and greater access to screening and treatment.


'/>"/>
SOURCE Susan G. Komen for the Cure Advocacy Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NBA Legend Dikembe Mutombo Joins Opportunity International Board of Advisors; Opens Doors in Democratic Republic of Congo
2. Social Justice Issues Take Main Stage at Egypts National Democratic Party Convention
3. Democratic Radio Address
4. Top Democratic Vote-Counter Concedes No Chance of Overriding SCHIP Veto
5. Women for Women International Congolese Country Director, Christine Karumba, Speaks Out About the Rape Epidemic in the Democratic Republic of the Congo.
6. Not Worthy of Support? Democratic Leaders Continue to Ignore Americas Youth
7. Smiling on the Campaign Trail - Cosmetic Dentist Michael Kosdon Rates the Candidates
8. Accipiter Life Sciences Announces Nomination of Three Independent Director Candidates for Election to the Penwest Board at the 2008 Annual Meeting
9. Aspen Health Stewardship Project Provides Means for Presidential Candidates to Reframe Health Care Reform
10. Growing Importance of March 4 Texas Primary Requires 2008 Presidential Candidates to Better Address Eldercare Financing Issues
11. NJ Voters Take Heed: Be Wary of Presidential Candidates Touting Universal Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is excited to ... water brand owners that topped the list as a result of their commitment to ... premier brand was Tibet 5100, a top notch water company that specializes in providing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 ... more than 200 of the country’s top healthcare executives to share insights on ... benefit of the Forum is the provider-centric perspective, experience, expertise and strategy shared ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience ... across their network of laboratory service centers across the country. Launched in April of ... in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's ... Convention Center. , As the longest running and largest worker's compensation event ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | ... | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical ... treatment of lupus and Sjogrens syndrome, today announced ... study in patients with systemic lupus erythematosus (SLE) ... --> --> Data from a ... of RSLV-132 in 32 subjects with SLE demonstrate ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... A Worldwide Clinical Trials expert will present at ... Plaza in London , 24-25 February 2016. ... advances for late phase research on Wednesday, 24 Feb at ... director of project management at Worldwide, will focus on how ... standards in late phase research. --> ...
Breaking Medicine Technology: